Pea proteins immunotherapy in peanut allergic mice model

Acta Alimentaria

Volumn 43, Issue 2, 2014, Pages 193-201

  Szymkiewicz, A ^a   Chudzik Kozlowska J ^a  

^a INSTITUTE OF ANIMAL REPRODUCTION AND FOOD RESEARCH   (Poland)

Author keywords

Animal model; Cross reactivity; Pea proteins; Peanut hypersensitivity; Specific immunotherapy

Indexed keywords

EID: 84987940052     PISSN: 01393006     EISSN: 15882535     Source Type: Journal    
DOI: 10.1556/AAlim.43.2014.2.1     Document Type: Article

References (21)

1. AKDIS, C.A. & AKDIS, M. (2009): Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J. Allergy Clin. Immunol., 123, 735-746.
2. ARPS, V., SUDOWE, S. & KÖLSCH, E. (1998): Antigen dose-dependent differences in IgE antibody production are not due to polarization towards Th1 and Th2 cell subsets. Eur. J. Immonol., 28, 681-686.
3. BLUMCHEN, K., ULBRICHT, H., STADEN, U., DOBBERSTEIN, K., BESCHORNER, J., DE OLIVEIRA, L.C., SHREFFLER, W.G., SAMPSON, H.A., NIGGEMANN, B., WAHN, U. & BEYER, K. (2010): Oral peanut immunotherapy in children with peanut anaphylaxis, J. Allergy Clin. Immunol., 126, 83-91.
4. FÆSTE, C.K. & NAMORK, E. (2010): Differentiated patterns of legume sensitization in peanut-allergic patients. Fd Anal. Meth., 3, 357-362.
5. FREITAS, R.L., FERREIRA, R.B. & TEIXEIRA, A.R. (2000): Use of a single method in the extraction of the seed storage globulins from several legume species. Application to analyze structural comparisons within the major classes of globulins. Int. J. Fd Sci. Nutr., 51, 341-352.
6. FREW, A.J. (2010): Allergen immunotherapy. J. Allergy Clin. Immunol., 125, 306-313.
7. HOURIHANE, J.B., KLIBURN, S.A., NORDLEE, J.A., HEFLE, S.L., TAYLOR, S.L. & WARNER, J.O. (1997): An evaluation of the sensitivity of subjects with peanut allergy to very low doses of peanut protein: a randomized, double-blind, placebo-controlled food challenge study. J. Allergy Clin. Immunol., 100, 596-600.
8. HSU, D.H., MOORE, K.W. & SPITS, H. (1992): Differential effects of IL-4 and IL-10 on IL-2-induced IFN-gamma synthesis and lymphokine-activated killer activity. Int. Immunol., 4, 563-569.
9. KHODOUN, M., STRAIT, R., OREKOV, T., HOGAN, S., KARASUYAMA, H., HERBERT, D.R., KOHL, J. & FINKELMAN, F.D. (2009): Peanuts can contribute to anaphylactic shock by activating component. J. Allergy Clin. Immunol., 123, 342-351.
10. KIM, E.H., BIRD, J.A., KULIS, M., LAUBACH, S., PONS, L., SHREFFLER, W., STEELE, P., KAMILARIS, J., VICKERY, B. & BURKS, A.W. (2011): Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J. Allergy Clin. Immunol., 127, 640-646.
11. LEE, S.Y., HUANG, C.K., ZHANG, T.F., SCHOFIELD, B.H., BURKS, A.W., BANNON, G.A. & SAMPSON, H.A. (2001): Oral administration of IL-12 suppresses anaphylactic reactions in a murine model of peanut hypersensitivity. Clin. Immunol., 101, 220-228.
12. LI, X.M., SEREBRISKY, D., LEE, S.Y., HUANG, C.K., BARDINA, L., SCHOFIELD, B.H., STANLEY, J.S., BURKS, A.W., BANNON, G.A. & SAMPSON, H.A. (2000): A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses. J. Allergy Clin. Immunol., 106, 150-158.
13. MADDALONI, M., STAATS, H.F., MIERZEJEWSKA, D., HOYT, M., ROBINSON, A., CALLIS, G., KOZAKI, S., KIYONO, H., MCGHEE, J.R., FUJIHASHI, K. & PASCUAL, D.W. (2006): Mucosal vaccine targeting improves onset of mucosal and systemic immunity to botulinum neurotoxin A. J. Immunol., 177, 5524-5532.
14. MALEKI, S.J., KOPPER, R.A., SHIN, D.S., PARK, C.W., COMPADARE, C.M., SAMPSON, H., BURKS, W. & BANNON, G.A. (2000): Structure of the major peanut allergen Ara h 1 may protect IgE-binding epitopes from degradation. J. Immunol., 164, 5844-5849.
15. OPPENHEIMER, J.J., NELSON, H.S., BOCK, S.A., CHRISTENSEN, F. & LEUNG, D.Y.M. (1992): Treatment of peanut allergy with rush immunotherapy. J. Allergy Clin. Immunol., 90, 256-262.
16. PONS, L., PONNAPPAN, U., HALL, R.A., SIMPSON, P., COCKRELL, G., WEST, M., SAMPSON, H.A., HELM, R.M. & BURKS, A.W. (2004): Soy immunotherapy for peanut-allergic mice: Modulation of the peanut-allergic response. J. Allergy Clin. Immunol., 114, 915-921.
17. ROLLAND, J.M., GARDNER, L.M. & O'HEHIR, R.E. (2009): Allergen-related approaches to immunotherapy. Pharmacol. Therapeutics, 121, 273-284.
18. SAVAGE, J.H., KAEDING, A.J., MATSUI, E.C. & WOOD, R.A. (2010): The natural history of soy allergy. J. Allergy Clin. Immunol., 125, 683-686.
19. STRAIT, R.T., MORRIS, S.C. & FINKELMAN, F.D. (2006): IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo trough both antigen interception and Fc gamma RIIb cross-linking. J. Clin. Invest., 116, 833-841.
20. THYAGARAJAN, A., VARSHNEY, P., JONES, S.M., SICHERER, S., WOOD, R., VICKERY, B.P., SAMPSON, H. & BURKS, A.W. (2010): Peanut oral immunotherapy is not ready for clinical use. J. Allergy Clin. Immunol., 126, 31-32.
21. UERMÖSI, C.H., BEERLI, R.R., BAUER, M., MANOLOVA, V., DIETMEIER, K., BUSER, R.B., KÜNDIG, T.M., SAUDAN, P. & BACHMANN, M.F. (2010): Mechanisms of allergen-specific desensitization. J. Allergy Clin. Immunol., 126, 375-383.